Literature DB >> 9934802

Age-specific PSA reference ranges in a group of non-urologic patients.

A C Atalay1, M I Karaman, S Güney, A Dalkiliç, A Y Müslümanoğlu, E Ergenekon.   

Abstract

Age-specific serum PSA reference ranges have recently been proposed to be more sensitive in young and more specific in elder patients. However, some conflicting results have been reported from different centers. In order to establish age-specific PSA reference ranges for our country, we measured the serum PSA levels of 400 healthy men over 40, between February 1995 and June 1996. Our study population consisted of men who had either PSA values lower than 4.0 ng/ml and normal digital rectal examination or negative prostatic biopsies taken for any reason. IMX assay was used for PSA determination in all patients. Mean PSA values and standard deviations for each age group were: 1.7+/-1.1 ng/ml for 40-49 years (n = 28), 2.0+/-1.2 ng/ml for 50-59 years (n = 110), 2.9+/-1.7 ng/ml for 60-69 years (n = 158) and 3.5+/-2.0 ng/ml for 70-79 years (n = 104). We conclude that further studies of larger series will lead us to standardize age-specific reference ranges in our country and, accordingly, we will be able to select the candidates for prostate biopsy more adequately.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9934802     DOI: 10.1007/bf02550550

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  15 in total

1.  Prostate-specific antigen as a marker for prostatic cancer: a monoclonal and a polyclonal immunoassay compared.

Authors:  D W Chan; D J Bruzek; J E Oesterling; R C Rock; P C Walsh
Journal:  Clin Chem       Date:  1987-10       Impact factor: 8.327

2.  Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.

Authors:  T A Stamey; N Yang; A R Hay; J E McNeal; F S Freiha; E Redwine
Journal:  N Engl J Med       Date:  1987-10-08       Impact factor: 91.245

3.  [Some physico-chemical characteristics of " -seminoprotein", an antigenic component specific for human seminal plasma. Forensic immunological study of body fluids and secretion. VII].

Authors:  M Hara; Y Koyanagi; T Inoue; T Fukuyama
Journal:  Nihon Hoigaku Zasshi       Date:  1971-07

4.  Precipitating antigens of the normal human prostate.

Authors:  R J Ablin; W A Soanes; P Bronson; E Witebsky
Journal:  J Reprod Fertil       Date:  1970-08

5.  Clinical use of prostate specific antigen in patients with prostate cancer.

Authors:  M A Hudson; R R Bahnson; W J Catalona
Journal:  J Urol       Date:  1989-10       Impact factor: 7.450

6.  Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia.

Authors:  A W Partin; H B Carter; D W Chan; J I Epstein; J E Oesterling; R C Rock; J P Weber; P C Walsh
Journal:  J Urol       Date:  1990-04       Impact factor: 7.450

7.  The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice.

Authors:  F M Rommel; V E Agusta; J A Breslin; H W Huffnagle; C E Pohl; P R Sieber; C A Stahl
Journal:  J Urol       Date:  1994-01       Impact factor: 7.450

8.  Effects of rectal examination, prostatic massage, ultrasonography and needle biopsy on serum prostate specific antigen levels.

Authors:  J J Yuan; D E Coplen; J A Petros; R S Figenshau; T L Ratliff; D S Smith; W J Catalona
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

9.  Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay.

Authors:  M Kuriyama; M C Wang; L D Papsidero; C S Killian; T Shimano; L Valenzuela; T Nishiura; G P Murphy; T M Chu
Journal:  Cancer Res       Date:  1980-12       Impact factor: 12.701

10.  Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.

Authors:  J E Oesterling; D W Chan; J I Epstein; A W Kimball; D J Bruzek; R C Rock; C B Brendler; P C Walsh
Journal:  J Urol       Date:  1988-04       Impact factor: 7.450

View more
  4 in total

1.  Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI.

Authors:  Dominique Jennings; B Nicholas Hatton; Jingyu Guo; Jean-Philippe Galons; Theodore P Trouard; Natarajan Raghunand; James Marshall; Robert J Gillies
Journal:  Neoplasia       Date:  2002 May-Jun       Impact factor: 5.715

2.  A Primary Care Provider's Guide to Preventive Health After Spinal Cord Injury.

Authors:  James Milligan; Stephen Burns; Suzanne Groah; Jeremy Howcroft
Journal:  Top Spinal Cord Inj Rehabil       Date:  2020

3.  Racial and ethnic variation of PSA in global population: Age specific reference intervals for serum prostate specific antigen in healthy South Indian males.

Authors:  T Malati; G Rajani Kumari
Journal:  Indian J Clin Biochem       Date:  2004-01

4.  The value of screening tests for detection of prostate cancer in 1000 saudi men.

Authors:  Baher A Kamal
Journal:  J Family Community Med       Date:  2004-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.